CARE Ratings Ltd

Meeting Details

• Event: Analyst/Institutional Investor Meeting with Oyster Rock Capital.
• Date/Time: 26 Aug 2026, 5:15 PM IST (rescheduled from 3:15 PM IST).
• Organizer: Oyster Rock Capital.
• Company representative: Company Secretary & Compliance Officer.
• Purpose: discussions based on publicly available information.
• Investor presentation available on CARE Ratings website.

Meeting Details

• Date: 3 September 2026.
• Time: 08:00 PM.
• Type/Mode: Virtual Analyst/Institutional Investor Meet.
• Organiser: TenCore Partners.

Participants

• No specific company participants named in the filing.

Purpose

• Discussions will be based on publicly available information.

Additional Notes

• Investor Presentation has been placed on CARE Ratings' website.

Meeting Details

• 12 Flags: 24 August 2026, 02:30 PM, Virtual.
• Bandhan Mutual Fund: 25 August 2026, 11:00 AM, In Person.
• Pari Washington: 26 August 2026, 02:00 PM, In Person.
• Oyster RockCapital: 26 August 2026, 03:15 PM, In Person.

Purpose

• Discussions will be based on publicly available information.

Additional Notes

• Investor Presentation already placed on CARE Ratings website.

Meeting Details

• Date: 27 August 2026; Time: 02:00 PM; Type/Mode: In-person; Event: Analyst/Institutional Investor Meet with Hill Fort Capital.

Participants

• Key company participants: management representatives (roles not named).

Purpose

• Purpose: Analyst/Institutional investor meet; discussions based on publicly available information.

Additional Notes

• Investor presentation has been placed on the company website.

Meeting Details

• Date and time: 12 August 2026, 10:00 AM onwards.
• Type/Mode: Group, physical investor meet.
• Organiser: EMKAY Confluence 2026.
• Location: Mumbai.

Participants

• Key company participants: Management team (roles not specified).

Purpose

• Purpose: Analyst/institutional investor meet based on publicly available information.

Additional Notes

• Investor presentation already placed on the company website; no transcript or recording mentioned.

Business Overview

• CareEdge offers ratings, analytics, consulting, and sustainability services as India's second-largest rating agency.
• Global subsidiaries include CARE Analytics & Advisory, CARE ESG Ratings, CareEdge Global IFSC, Africa, Nepal, South Africa.
• Strategic initiatives focus on expanding non-ratings verticals and hosting CareEdge Conversations and Sovereign Rating Outlook events.

Financial Performance

• Consolidated revenue ₹98.71 crore; standalone revenue growth 16.5% YoY; consolidated revenue growth 18.9% YoY.
• Ratings business revenue ₹12.97 crore; non-ratings revenue ≈₹85.74 crore.

Operational Highlights

• Q1 FY27: consolidated revenue ₹98.71 crore; ratings ₹12.97 crore; non-ratings ₹85.74 crore.
• Flagship CareEdge Debt Market Summit 2026 hosted in Mumbai.
• CareEdge Global Sovereign Rating Outlook launched in London.
• Outreach events in India and globally; CareEdge Conversations highlighted by SEBI Chairman presence.
• Subsidiaries contributed to consolidated growth.

Outlook & Strategy

• Strategy focuses on expanding ratings analytics, consulting, and international footprint.
• Guidance: performance to be evaluated annually; focus on sustainable growth and risk analytics leadership.

Risks & Mitigation

• Macro risks: global uncertainties, El Niño, and domestic monsoon conditions.
• Mitigation: strengthen core ratings business and diversify non-ratings revenue.

Consolidated results

• Consolidated revenue from operations (net): 11,167.95 lakh.
• Consolidated total income: 12,647.89 lakh.
• Consolidated PBT: 4,497.18 lakh.
• Consolidated tax expense: 1,197.92 lakh.
• Consolidated net profit: 3,299.26 lakh.
• Consolidated basic EPS: 10.73; diluted 10.70.
• Segment revenue: ratings 9,871.37; others 1,350.51; total 11,221.88.

Standalone results

• Standalone revenue from operations: 8,815.14 lakh.
• Standalone total income: 10,378.56 lakh.
• Standalone PBT: 4,503.44 lakh.
• Standalone tax expense: 1,115.08 lakh.
• Standalone net profit: 3,388.36 lakh.
• Standalone basic EPS: 11.27; diluted 11.24.
• Standalone ESOS expense: 43.85 lakh.

Governance & approvals

• Board approved unaudited results on Aug 7, 2026.
• Results prepared per SEBI Regulation 33 format.

Meeting Details

• Board meeting on August 7, 2026; time and venue not disclosed.

Key Agenda Items

• Consider and approve unaudited standalone and consolidated financial results for the quarter ended June 30, 2026.

Other Notes

• Trading window closed from July 1, 2026; remains closed until 48 hours after results declaration.